Kuros Biosciences Ltd. (CSBTF)
31.91
0.00 (0.00%)
USD |
OTCM |
Feb 06, 16:00
Kuros Biosciences Enterprise Value : 1.247B for Feb. 6, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| EvoNext Holdings SA | -- |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 36.98B |
| AC Immune SA | 185.42M |
Enterprise Value Related Metrics
| Earnings Yield | -0.58% |
| Operating Earnings Yield | 0.40% |
| Normalized Earnings Yield | -0.2391 |